Scott R. Smith

Scott R. Smith

Auto-generated profile, based on publicly available information

Scott R. Smith

Division of Pharmaceutical Policy and Evaluative Sciences, School of Pharmacy, University of North Carolina (UNC), Chapel Hill 27599-7360, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Patient Education and Counseling
Verified
Journal Article
Closed access
SSScott R Smith
Scott R Smith
JRJohn C Rublein
John C Rublein
CMCheryl Marcus
Cheryl Marcus
TBTina Brock
Tina Brock
MCMargaret A Chesney
Margaret A Chesney

1 June 2004 in American Journal of Health-System Pharmacy
Verified
Journal Article
Open access
PDF file
SSScott R. Smith
Scott R. Smith
CGCarol E. Golin
Carol E. Golin
SRSusan Reif
Susan Reif
Purpose: The medication counseling practices of pharmacists caring for patients with HIV infection and the factors influencing their counseling behaviors regarding antiretroviral medications were examined. Methods: A questionnaire was mailed in February 2000 to pharmacist-managers of 573 ambulatory care pharmacies providing medications to beneficiaries of the North Carolina AIDS Drug Assistance Program. The frequency of and attitudes about adherence counseling for patients with HIV infection; the time allocated, spent, and needed to provide high-quality care to these patients; and pharmacists' time pressure and time stress were measured. Results: Of the 573 questionnaires mailed, 440 (77%) were usable. Fifty-nine percent of pharmacists reported that they did not have enough time to provide adherence counseling to patients receiving antiretroviral medications, and 45% reported that most of their patients did not receive such counseling. Time-stressed pharmacists were significantly less likely to perform 12 of 22 counseling behaviors, including discussing adverse effects (13% versus 24%, p < 0.0089), drug interactions (13% versus 31%, p < 0.0001), and what to do if a dose is missed (8% versus 23%, p < 0.0001). Multivariate analysis revealed that time stress, perceived skill and interest in adherence counseling, and job satisfaction were significantly associated with the counseling index. Conclusion: Time pressure and other barriers appeared to limit the care that some pharmacists offered to patients with HIV infection. Pharmacist age, job satisfaction, and perceived skill and interest in adherence counseling influenced the comprehensiveness of the counseling pharmacists provided for patients receiving antiretroviral medications.

1 September 2002 in The Lancet
Verified
Journal Article
Closed access
SSScott R Smith
Scott R Smith

1 October 2001 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
SSScott R. Smith
Scott R. Smith
DKDuane M. Kirking
Duane M. Kirking
Background:Insurance coverage facilitates access to life-saving medications for many patients with HIV disease. Thus, the effects of insurance coverage changes, such as the gain or loss of coverage, may be important in explaining patient access and adherence to the medications used in the treatment of HIV disease. Objectives:The study's objective was to examine whether changes in health insurance coverage affect rates of prescription drug use by patients with HIV disease. Methods:Data were ascertained from adults participating in a series of up to six interviews as part of the AIDS Costs and Services Utilization Survey (ACSUS). ACSUS was an 18-month panel survey of patients in care for HIV/AIDS at 26 sites located in 10 U.S. cities. Poisson regression analyses with generalized estimating equations were conducted to determine the effects of demographic and socioeconomic variables on the acquisition rate of antiretrovirals, antipneumocystics, and antidepressants. The analytic sample consisted of 1566 respondents who provided 6518 interviews. Results:Although changes in insurance coverage were common, complete loss of insurance was reported in only 1.5% of the interviews whereas gaining insurance was reported in 3.3% of interviews. Having no coverage was associated with significantly lower rates of antiretroviral (rate ratio [RR], 0.73), antipneumocystic (RR, 0.58) and antidepressant use (RR, 0.31). Gaining insurance coverage was associated with lower antiretroviral (RR, 0.75) and antipneumocystic (RR, 0.70) use whereas losing insurance was associated with lower antiretroviral use (RR, 0.58). In multivariate analyses, these associations remained. Conclusions:Changes in health insurance coverage are associated with lower rates of drug use for some medications used by patients with HIV disease. Address correspondence and reprint requests to Scott R. Smith, Division of Pharmaceutical Policy and Evaluative Sciences, 205 Beard Hall, Campus Box #7360, Chapel Hill, NC 27599-7360 U.S.A.; e-mail: [email protected] Manuscript received July 31, 2000; accepted June 28, 2001. © 2001 Lippincott Williams & Wilkins, Inc.